650 related articles for article (PubMed ID: 19286255)
21. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
[TBL] [Abstract][Full Text] [Related]
22. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T; Brady HJ
Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
[TBL] [Abstract][Full Text] [Related]
23. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
24. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
[TBL] [Abstract][Full Text] [Related]
25. [Infant acute leukemia].
Brethon B; Cavé H; Fahd M; Baruchel A
Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
[TBL] [Abstract][Full Text] [Related]
26. [Leukemia in neonates and infants].
Sońta-Jakimczyk D; Szczepański T
Przegl Lek; 2003; 60 Suppl 5():9-12. PubMed ID: 14575001
[TBL] [Abstract][Full Text] [Related]
27. Leukemias of indeterminant lineage.
Lee EJ; Schiffer CA
Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
[TBL] [Abstract][Full Text] [Related]
28. [A case of hybrid acute leukemia in a a child].
Kiss C; Kiss A; Kovács I; Oláh E; Balogh E; Karmazsin L
Orv Hetil; 1990 Nov; 131(44):2431-3. PubMed ID: 2243698
[TBL] [Abstract][Full Text] [Related]
29. Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia.
Stasik C; Ganguly S; Cunningham MT; Hagemeister S; Persons DL
Cancer Genet Cytogenet; 2006 Jul; 168(2):146-9. PubMed ID: 16843104
[TBL] [Abstract][Full Text] [Related]
30. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
Mehta PA; Davies SM
Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
[No Abstract] [Full Text] [Related]
31. Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.
Li A; Goldwasser MA; Zhou J; Armstrong SA; Wang H; Dalton V; Fletcher JA; Sallan SE; Silverman LB; Gribben JG
Br J Haematol; 2005 Oct; 131(2):185-92. PubMed ID: 16197448
[TBL] [Abstract][Full Text] [Related]
32. Acute monoblastic leukemia that switched lineage at relapse to acute lymphoblastic leukemia: a case report.
Inoue A; Kawakami C; Takitani K; Ikemoto T; Tamai H
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e258-60. PubMed ID: 22217491
[TBL] [Abstract][Full Text] [Related]
33. [Importance of the detection of minimal residual disease in the management of acute leukemia].
Mód A; Tamáska J; Adám E; Gidáll J; Poros A; Király A; Natonek K; Pálóczi K; Hollán Z
Orv Hetil; 1991 Jun; 132(24):1291-6, 1299. PubMed ID: 1857605
[TBL] [Abstract][Full Text] [Related]
34. Stem cell transplant in the treatment of childhood biphenotypic acute leukemia.
Park JA; Ghim TT; Bae Kw; Im HJ; Jang SS; Park CJ; Chi HS; Seo JJ
Pediatr Blood Cancer; 2009 Sep; 53(3):444-52. PubMed ID: 19489056
[TBL] [Abstract][Full Text] [Related]
35. Hybrid acute leukemia: therapeutical implications of immunological phenotyping.
Kristensen JS; Jensen AW; Jensen IM; Pedersen B; Ellegaard J; Hokland P
Anal Cell Pathol; 1992 Mar; 4(2):69-79. PubMed ID: 1550796
[TBL] [Abstract][Full Text] [Related]
36. [Relapse of biphenotypic leukemia confirmed by molecular study].
Onozawa M; Hashino S; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Tanaka J; Imamura M; Asaka M
Rinsho Ketsueki; 2004 Feb; 45(2):161-3. PubMed ID: 15045826
[TBL] [Abstract][Full Text] [Related]
37. Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis.
Bellido M; Martino R; Aventín A; Carnicer MJ; Rubiol E; López O; Sierra J; Nomdedéu JF
Haematologica; 2000 Oct; 85(10):1083-6. PubMed ID: 11025601
[TBL] [Abstract][Full Text] [Related]
38. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
39. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
Borowitz MJ; Pullen DJ; Winick N; Martin PL; Bowman WP; Camitta B
Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
[TBL] [Abstract][Full Text] [Related]
40. Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?
Stone RM
Best Pract Res Clin Haematol; 2011 Dec; 24(4):509-14. PubMed ID: 22127313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
